Increasing FLT3-ITD length increases expression of bcl-xl in AML.

被引：0
|
作者：
Seedhouse, Claire H. [1 ]
Pallis, Monica [1 ]
Grundy, Martin [1 ]
Russell, Nigel [1 ]
机构：
[1] Univ Nottingham Hosp, City Hosp Campus, Clin Sci Building, Nottingham NG7 2UH, England
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.1909.1909
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1909
引用
收藏
页码：541A / 541A
页数：1
相关论文
共 50 条
  • [41] Impact of FLT3-ITD length on prognosis of acute myeloid leukemia
    Liu, Song-Bai
    Dong, Hao-Jie
    Bao, Xie-Bing
    Qiu, Qiao-Cheng
    Li, Hong-Zhi
    Shen, Hong-Jie
    Ding, Zi-Xuan
    Wang, Chao
    Chu, Xiao-Ling
    Yu, Jing-Qiu
    Tao, Tao
    Li, Zheng
    Tang, Xiao-Wen
    Chen, Su-Ning
    Wu, De-Pei
    Li, Ling
    Xue, Sheng-Li
    HAEMATOLOGICA, 2019, 104 (01) : E9 - E12
  • [42] Improving sensitivity of FLT3-ITD analysis in patients with AML by investigation of RNA
    Porret, Naomi A.
    Joncourt, Raphael
    Andres, Martin
    Baerlocher, Gabriela M.
    Angelillo-Scherrer, Anne
    Pabst, Thomas
    Bacher, Ulrike
    Leibundgut, Elisabeth Oppliger
    SWISS MEDICAL WEEKLY, 2018, 148 : 10S - 10S
  • [43] ADVERSE PROGNOSIS OF LOW AR FLT3-ITD IN AML AND CLINICAL BENEFIT OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN AML PATIENTS WITH LOW AR FLT3-ITD AND NPM1
    Kim, Hyeoung-Joon
    Kim, TaeHyung
    Kook, Hoon
    Song, Ga-Young
    Ahn, Seo-Yeon
    Jung, Sung-Hoon
    Kim, Mihee
    Yang, Deok-Hwan
    Lee, Je-Jung
    Choi, Seung Hyun
    Kim, Mi Yeon
    Jung, Chul Won
    Jang, Jun-Ho
    Kim, Hee Je
    Moon, Joon Ho
    Sohn, Sang Kyun
    Won, Jong-Ho
    Park, Seong-Kyu
    Kim, Sung-Hyun
    Zhang, Zhaolei
    Ahn, Jae-Sook
    Kim, Dennis Dong Hwan
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 172 - 173
  • [44] Donor HSCs with a preexisting ASXL1-mutation led to the development of FLT3-ITD positive AML in the donor and FLT3-ITD negative AML in the recipient after unrelated transplant
    Zhongwen Liu
    Hongxing Liu
    Mingyue Shi
    Hafiz Abdul Waqas Ahmed
    Lei Huo
    Yanli Zhang
    Dai Kong
    Meiying Wen
    Fang Wang
    Mingyi Chen
    William J. Murphy
    Kai Sun
    Bone Marrow Transplantation, 2018, 53 : 499 - 502
  • [45] Crenolanib besylate, a type I pan-FLT3 inhibitor, to demonstrate clinical activity in multiply relapsed FLT3-ITD and D835 AML.
    Cortes, Jorge E.
    Kantarjian, Hagop M.
    Kadia, Tapan M.
    Borthakur, Gautam
    Konopleva, Marina
    Garcia-Manero, Guillermo
    Daver, Naval Guastad
    Pemmaraju, Naveen
    Jabbour, Elias
    Estrov, Zeev
    Ramachandran, Abhijit
    Paradela, Jamil
    Pond, Blake
    Ravandi, Farhad
    Vusirikala, Madhuri
    Patel, Prapti Arvind
    Levis, Mark J.
    Perl, Alexander E.
    Andreeff, Michael
    Collins, Robert
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [46] Donor HSCs with a preexisting ASXL1-mutation led to the development of FLT3-ITD positive AML in the donor and FLT3-ITD negative AML in the recipient after unrelated transplant
    Liu, Zhongwen
    Liu, Hongxing
    Shi, Mingyue
    Ahmed, Hafiz Abdul Waqas
    Huo, Lei
    Zhang, Yanli
    Kong, Dai
    Wen, Meiying
    Wang, Fang
    Chen, Mingyi
    Murphy, William J.
    Sun, Kai
    BONE MARROW TRANSPLANTATION, 2018, 53 (04) : 499 - 502
  • [47] Role of Autophagy in Resistance of FLT3-ITD AML Stem Cells to FLT3 TKI Treatment
    Qiu, Shaowei
    Yan, Chengcheng
    Paterson, Andrew J.
    Li, Hui
    Anderson, Nick
    Abraham, Ajay
    He, Jianbo
    Shah, Mansi
    Agarwal, Puneet
    Yang, Jing
    Xie, Min
    Lu, Rui
    Welner, Rob S.
    Bhatia, Ravi
    BLOOD, 2019, 134
  • [48] Evaluating Impact of Insertion Length on Clinical Outcomes in FLT3-ITD Mutated AML: A Single Center Retrospective Analysis
    Rauf, Asad
    Nurse, Daniel P.
    El-Asmar, Jessica
    Bawwab, Ameed
    Abu-Farsakh, Yomna
    Albliwi, Moath
    Hanna, John
    Abuamsha, Hasan
    Batah, Heya
    Zabor, Emily C.
    Bedelu, Yohanna B.
    Chen, Mark Jinan
    Nakitandwe, Joy
    Younes, Ismail Elbaz
    Bosler, David S.
    Jain, Akriti G.
    Molina, John C.
    Balderman, Sophia R.
    Singh, Abhay
    Gerds, Aaron T.
    Mukherjee, Sudipto
    Advani, Anjali S.
    Carraway, Hetty E.
    Mustafa, Moaath K.
    BLOOD, 2024, 144 : 6143 - 6144
  • [49] TERMINAL DEOXYNUCLEOTIDYL TRANFERASE (TDT) EXPRESSION IS ASSOCIATED WITH FLT3-ITD MUTATIONS IN ACUTE MYELOID LEUKEMIA (AML)
    De Bellis, E.
    Ottone, T.
    Mercante, L.
    Falconi, G.
    Cugini, E.
    Consalvo, M. I.
    Travaglini, S.
    Paterno, G.
    Piciocchi, A.
    Rossi, E. L. Lindfors
    Gurnari, C.
    Maurillo, L.
    Buccisano, F.
    Arcese, W.
    Voso, M. T.
    HAEMATOLOGICA, 2020, 105 : S89 - S90
  • [50] Acquired Isodisomy for chromosome 13 is common in AML, and associated with FLT3-itd mutations
    M Griffiths
    J Mason
    M Rindl
    S Akiki
    D McMullan
    V Stinton
    H Powell
    A Curtis
    N Bown
    C Craddock
    Leukemia, 2005, 19 : 2355 - 2358
12345